Day: August 22, 2022

DENVER, Aug. 22, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company“), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $6.2 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering equates to 5,576,087 shares at a price to the public of $1.12 per share. The Company intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, repayment of indebtedness and increasing working capital expenditures. In addition, the Company granted the underwriters a 45-day option to purchase additional shares of...

CARLSBAD, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release for the second quarter ended June 30, 2022, on Monday, August 29, 2022. Management will host a conference call that day at 11:00 a.m. Eastern Time to discuss the results. Second Quarter 2022 Conference Call Details Date and Time: Monday, August 29, 2022, at 11:00 a.m. ET Call-in Information: Interested parties can access the conference call by dialing (844) 861-5497 or (412) 317-5794. Webcast: Interested parties can access the conference call via a live webcast, which is available via the following link: https://app.webinar.net/0617xnKbZaA...

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse Cardiovascular Events with the BET Protein Inhibitor Apabetalone in Patients with Recent Acute Coronary Syndrome, Type 2 Diabetes, and Moderate to High Likelihood of Non-Alcoholic Fatty Liver Disease” in the American Journal of Preventive Cardiology. The article presents a post-hoc analysis of BETonMACE data, which demonstrates apabetalone treatment improves cardiac outcomes and liver fibrosis scores in patients with moderate-to-high likelihood of advanced liver fibrosis. The article is published online HERE. “In this patient group, apabetalone treatment was associated not only with fewer negative cardiovascular outcomes, but also...

GrønlandsBANKEN A/S is exploring the possibility to issue Tier 2 capital and Senior Non-Preferred  As part of the ongoing effort to optimise its capital structure, GrønlandsBANKEN A/S has decided to explore the possibility of issuing new Tier 2 capital and Senior Non-Preferred. If there is satisfactory market interest, the issues are expected to be completed before the end of the third quarter of 2022. Nykredit Bank A/S has been mandated as sole lead arranger. Eventuelle henvendelser kan rettes til: The Bank of GreenlandMartin KviesgaardManaging Director Telephone: +299 34 78 02E-mail: mbk@banken.glAttachment12.Undersøgelse – udstedelse af supplerende kapital_UK

VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) — P2 Gold Inc. (“P2” or the “Company”) (TSX-V:PGLD), reports results from the first drill holes (BAM-007 to 015) of the 2022 Drill Program at its gold-copper BAM Project located in the Golden Triangle in northwest British Columbia. “The 2022 Drill Program is off to a great start at BAM with two drills turning and 6,100 meters completed in 45 holes,” commented Joe Ovsenek, President and CEO of P2. “These initial 2022 results are highly encouraging and follow up on the four 2021 holes which led to the discovery of the Monarch Gold Zone. Each new drill hole adds more to our geologic understanding as we work to expand the near-surface epithermal mineralization, and once we have the deep geophysics in hand, we will start to target and test for the source.” BAM Project Drill...